ANGEL STANLEY: Open Payments
NPI 1821470725 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$788 in 22 payments from 7 companies in 2025. Trend: 2023 $18 · 2024 $88 · 2025 $788
Food & beverage: $788
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $299 |
| Teva Pharmaceuticals USA, Inc. | 6 | $273 |
| Alkermes, Inc. | 3 | $70 |
| ABBVIE INC. | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $55 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| Luye Pharma (USA) Ltd. | 1 | $15 |
Products named: CAPLYTA, AUSTEDO XR, VRAYLAR, UZEDY, ARISTADA, ABILIFY ASIMTUFII, LYBALVI, ABILIFY MAINTENA.
Industry payments across NY — which companies pay providers there.
